Hosted on MSN8d
Will AI revolutionize drug development? Researchers explain why it depends on how it's usedThe current drug development process operates like an assembly line, relying on a checkbox approach with extensive testing at each step of the process. While AI may be able to reduce the time and cost ...
Obesity continues to grab attention at the J.P. Morgan Healthcare Conference in San Francisco, with both Pfizer and Kailera ...
Researchers at the University of Oklahoma have developed a breakthrough method of adding a single nitrogen atom to molecules, ...
By combining diverse datasets and powerful analytical and modeling tools, drug developers are finding more potential ...
Top-line Phase 2/3 data readout for CTX-009, now named tovecimig (a DLL4 x VEGF-A bispecific), in patients with biliary tract cancer (BTC) is on ...
Neumora Therapeutics, Inc. (NASDAQ:NMRA) stock traded lower after the company released data from the Phase 3 KOASTAL-1 Study ...
SciTech Development, a clinical-stage pharmaceutical company specializing in oncology, is pleased to announce the initiation ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback